The EPA’s overly cautious approach is also leading to a backlog of new chemicals awaiting approval in the US, industry representatives claimed at the hearing. The backlog is forcing manufacturers to ...
The company Light Horse Therapeutics, which launched after the tournament ended, leverages genome editing to find oncology targets that a small molecule could act on. Its name evokes a majestic ...